Insider Trading activities of Penwest Pharmaceuticals Co insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Penwest Pharmaceuticals Co since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Penwest Pharmaceuticals Co since year 2005. Table 2 shows the detailed insider transactions of Penwest Pharmaceuticals Co since 2005. The reporting company's ticker symbol is PPCO. The reporting company's CIK number is 1047188.
The total value of stock buying since 2005 is $26,016,529.
The total value of stock sales since 2005 is $3,765,972.
The total value of stock option exercises since 2005 is $1,731,849.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Penwest Pharmaceuticals Co (PPCO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2010-11 3,173,334 $0 0 $0 0 $0
2010-04 0 $0 0 $0 36,500 $56,940
2009-11 7,500 $16,050 0 $0 0 $0
2009-09 0 $0 3,466 $8,145 0 $0
2009-03 750,762 $1,062,875 0 $0 0 $0
2009-02 804,640 $1,302,544 0 $0 0 $0
2009-01 1,063,900 $2,267,395 0 $0 0 $0
2008-12 9,300 $46,500 0 $0 0 $0
2008-10 3,900 $19,500 0 $0 0 $0
2008-09 13,500 $67,500 0 $0 0 $0
2008-06 91,500 $457,500 5,000 $15,425 0 $0
2008-05 5,000 $25,000 4,000 $10,540 0 $0
2008-03 3,694,300 $18,299,690 0 $0 0 $0
2008-02 49,100 $260,636 0 $0 0 $0
2008-01 455,000 $2,175,035 0 $0 0 $0
2007-09 1,500 $16,304 0 $0 0 $0
2007-08 0 $0 0 $0 4,489 $27,472
2007-05 0 $0 0 $0 1,999 $15,012
2006-12 0 $0 83,333 $1,386,577 83,333 $841,663
2006-09 0 $0 3,213 $56,388 0 $0
2006-06 0 $0 40,000 $878,170 40,000 $377,750
2006-05 0 $0 18,363 $368,067 0 $0
2006-02 0 $0 23,750 $531,062 23,750 $191,812
2006-01 0 $0 17,000 $343,286 17,000 $188,020
2005-12 0 $0 3,000 $59,112 3,000 $33,180
2005-09 0 $0 7,000 $109,200 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Penwest Pharmaceuticals Co insiders (PPCO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-11-04 West Acquisition Corp. (10% Owner) Buy 3,173,334 .00 0
2010-04-28 Hawi Amale (SVP, Pharmaceutical Dev.) Option Ex 6,500 1.56 10,140
2010-04-28 Baichwal Anand (SVP Licensing & BD) Option Ex 5,000 1.56 7,800
2010-04-28 Good Jennifer L (President & CEO) Option Ex 25,000 1.56 39,000
2009-11-11 Good Jennifer L (President & CEO) Buy 7,500 2.14 16,050
2009-09-03 Freiman Paul E (Director) Sale 3,466 2.35 8,145
2009-03-11 Tang Capital Partners Lp (10% Owner) Buy 25,100 1.33 33,383
2009-03-10 Tang Capital Partners Lp (10% Owner) Buy 35,000 1.43 50,050
2009-03-09 Tang Capital Partners Lp (10% Owner) Buy 296,362 1.39 411,646
2009-03-06 Tang Capital Partners Lp (10% Owner) Buy 309,300 1.43 441,061
2009-03-05 Tang Capital Partners Lp (10% Owner) Buy 85,000 1.49 126,735
2009-02-25 Tang Capital Partners Lp (10% Owner) Buy 69,200 1.50 103,523
2009-02-24 Tang Capital Partners Lp (10% Owner) Buy 1,300 1.51 1,966
2009-02-23 Tang Capital Partners Lp (10% Owner) Buy 24,140 1.42 34,230
2009-02-19 Tang Capital Partners Lp (10% Owner) Buy 45,000 1.47 66,240
2009-02-17 Tang Capital Partners Lp (10% Owner) Buy 665,000 1.65 1,096,585
2009-01-16 Perceptive Advisors Llc (10% Owner) Buy 23,900 5.00 119,500
2009-01-09 Tang Capital Partners Lp (10% Owner) Buy 1,015,000 1.99 2,022,895
2009-01-06 Perceptive Advisors Llc (10% Owner) Buy 25,000 5.00 125,000
2008-12-29 Perceptive Advisors Llc (10% Owner) Buy 7,000 5.00 35,000
2008-10-24 Perceptive Life Sciences Master Fund Ltd (10% Owner) Buy 3,000 5.00 15,000
2008-10-15 Perceptive Life Sciences Master Fund Ltd (10% Owner) Buy 600 5.00 3,000
2008-09-29 Perceptive Life Sciences Master Fund Ltd (10% Owner) Buy 9,000 5.00 45,000
2008-06-23 Edelman Joseph (10% Owner) Buy 91,500 5.00 457,500
2008-06-10 Freiman Paul E (Director) Sale 5,000 3.08 15,425
2008-05-15 Bradley Scott (10% Owner) Buy 2,500 5.00 12,500
2008-05-12 Freiman Paul E (Director) Sale 4,000 2.64 10,540
2008-05-07 Bradley Scott (10% Owner) Buy 2,500 5.00 12,500
2008-03-20 Bradley Scott (10% Owner) Buy 1,340,300 5.83 7,817,969
2008-03-18 Bradley Scott (10% Owner) Buy 800 7.50 6,000
2008-03-12 Bradley Scott (10% Owner) Buy 7,400 5.00 37,000
2008-03-11 Bradley Scott (10% Owner) Buy 1,937,900 4.04 7,829,116
2008-03-10 Bradley Scott (10% Owner) Buy 342,200 6.67 2,281,105
2008-03-05 Bradley Scott (10% Owner) Buy 52,100 5.00 260,500
2008-03-04 Bradley Scott (10% Owner) Buy 13,600 5.00 68,000
2008-02-20 Bradley Scott (10% Owner) Buy 600 7.50 4,500
2008-02-19 Bradley Scott (10% Owner) Buy 1,500 7.50 11,250
2008-02-12 Bradley Scott (10% Owner) Buy 5,000 4.14 20,690
2008-02-01 Bradley Scott (10% Owner) Buy 42,000 5.34 224,196
2008-01-31 Bradley Scott (10% Owner) Buy 160,000 4.97 795,680
2008-01-30 Bradley Scott (10% Owner) Buy 170,000 4.74 806,480
2008-01-29 Bradley Scott (10% Owner) Buy 125,000 4.58 572,875
2007-09-14 Palleiko Benjamin L (SVP, Corporate Dev. & CFO) Buy 1,500 10.87 16,304
2007-08-07 Freiman Paul E (Director) Option Ex 4,489 6.12 27,472
2007-05-29 Freiman Paul E (Director) Option Ex 1,999 7.51 15,012
2006-12-11 Hennessey Robert (Director) Sale 83,333 16.64 1,386,577
2006-12-11 Hennessey Robert (Director) Option Ex 83,333 10.10 841,663
2006-09-05 Baichwal Anand (Chief Scientific Officer) Sale 3,213 17.55 56,388
2006-06-27 Joslyn Alan (Sr. Vice President, R&D.) Sale 15,000 21.97 329,565
2006-06-27 Joslyn Alan (Sr. Vice President, R&D.) Option Ex 15,000 11.06 165,900
2006-06-26 Joslyn Alan (Sr. Vice President, R&D.) Sale 10,000 21.78 217,750
2006-06-26 Joslyn Alan (Sr. Vice President, R&D.) Option Ex 10,000 11.06 110,600
2006-06-23 Baichwal Anand (Chief Scientific Officer) Sale 15,000 22.06 330,855
2006-06-23 Baichwal Anand (Chief Scientific Officer) Option Ex 15,000 6.75 101,250
2006-05-08 Baichwal Anand (Chief Scientific Officer) Sale 6,863 20.20 138,632
2006-05-05 Baichwal Anand (Chief Scientific Officer) Sale 1,500 20.29 30,435
2006-05-01 Freiman Paul E (Director) Sale 10,000 19.90 199,000
2006-02-17 Joslyn Alan (Sr. Vice President, R&D.) Sale 4,000 23.51 94,032
2006-02-17 Joslyn Alan (Sr. Vice President, R&D.) Option Ex 4,000 10.35 41,400
2006-02-16 Joslyn Alan (Sr. Vice President, R&D.) Sale 4,750 23.16 110,000
2006-02-16 Joslyn Alan (Sr. Vice President, R&D.) Option Ex 4,750 10.35 49,162
2006-02-03 Baichwal Anand (Chief Scientific Officer) Sale 15,000 21.80 327,030
2006-02-03 Baichwal Anand (Chief Scientific Officer) Option Ex 15,000 6.75 101,250
2006-01-26 Joslyn Alan (Sr. Vice President,) Sale 10,000 20.07 200,720
2006-01-26 Joslyn Alan (Sr. Vice President,) Option Ex 10,000 11.06 110,600
2006-01-05 Joslyn Alan (Sr. Vice President,) Sale 5,000 20.51 102,550
2006-01-05 Joslyn Alan (Sr. Vice President,) Option Ex 5,000 11.06 55,300
2006-01-04 Joslyn Alan (Sr. Vice President,) Sale 2,000 20.01 40,016
2006-01-04 Joslyn Alan (Sr. Vice President,) Option Ex 2,000 11.06 22,120
2005-12-23 Joslyn Alan (Sr. Vice President,) Sale 2,000 19.81 39,612
2005-12-23 Joslyn Alan (Sr. Vice President,) Option Ex 2,000 11.06 22,120
2005-12-22 Joslyn Alan (Sr. Vice President,) Sale 1,000 19.50 19,500
2005-12-22 Joslyn Alan (Sr. Vice President,) Option Ex 1,000 11.06 11,060
2005-09-08 Baichwal Anand (Chief Scientific Officer) Sale 7,000 15.60 109,200

Insider trading activities including stock purchases, stock sales, and option exercises of PPCO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Penwest Pharmaceuticals Co (symbol PPCO, CIK number 1047188) see the Securities and Exchange Commission (SEC) website.